Model to Predict Coinfection in Elderly Patients With COVID-19
NCT ID: NCT06321367
Last Updated: 2024-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2022-12-20
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 Serology and Immunosenescence
NCT04563650
Clinical and Biological Predictors of COVID-19 Disease in Older Patients
NCT04348396
Correlation Between Antibiotic Resistance and Incidence of Sepsis in Community Acquired Pneumonia
NCT05606627
Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management
NCT04668170
Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic
NCT06349707
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
elderly COVID-19 patients with coinfection
No interventions assigned to this group
elderly COVID-19 without coinfection
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* COVID-19 was diagnosed with SARS-CoV-2 reverse transcription-polymerase chain reaction positive or rapid antigen test positive or a clinical diagnosis made by the radiological responsible clinician based on signs, symptoms, or radiology consistent with COVID-19;
* Hospitalization more than one day, including patients in emergency.
Exclusion Criteria
* Pregnancy;
* Hospitalization less than one day;
* Outpatients;
* Patients with missing or incomplete information.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xiangya Hospital of Central South University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xiangya Hospital of Central South University
Changsha, Hunan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
82070613
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
82370638
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2022RC1212
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2023JJ10095
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
202401002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.